Active substances

Obeticolic acid›

A05AA04 Alimentary tract and metabolism | Bile therapy | Bile acids and derivatives

Indicated for: primary biliary cholangitis

Obidoxime chloride›

V03AB13 Various | All other therapeutic products | All other therapeutic products | Antidotes

Indicated for: poisoning

Obinutuzumab›

L01FA03 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors

Indicated for: hematologic malignancies

Ocrelizumab›

L04AG08 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Monoclonal antibodies

Indicated for: multiple sclerosis

Ocriplasmin›

S01XA22 Sensory organs | Other ophthalmologicals

Indicated for: vitreomacular traction

Octenidine›

R02AA21 Respiratory system | Throat preparations | Throat preparations | Antiseptics

Indicated for: wounds; local antisepsis

Octenidine + phenoxyethanol›

D08AJ57 Dermatologicals | Antiseptics and disinfectants | Antiseptics and disinfectants | Quaternary ammonium compounds

Indicated for: wounds; local antisepsis

Octocog alfa›

B02BD02 Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors

Indicated for: bleeding; coagulation disorders

Octreotide›

H01CB02 Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Somatostatin and analogues

Indicated for: acromegaly; neuroendocrine tumors

Odevixibat›

A05AX05 Alimentary tract and metabolism | Bile therapy | Other drugs for bile therapy

Indicated for: cholestatic pruritus

Ofatumumab›

L01FA02 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors

Indicated for: multiple sclerosis

Ofloxacin›

S01AE01 Sensory organs | Antiinfectives | Fluoroquinolones

Indicated for: bacterial infections

Olanzapine›

N05AH03 Nervous system | Antipsychotics | Diazepines, oxazepines, thiazepines and oxepines

Indicated for: schizophrenia; bipolar disorder

Olaparib›

L01XX46 Antineoplastic and immunomodulating agents | Other antineoplastic agents

Indicated for: cancer

Olaratumab›

L01XC27 Antineoplastic and immunomodulating agents | Other antineoplastic agents | Monoclonal antibodies

Indicated for: cancer

Olezarsen›

Indicated for: dyslipidemia

Olipudas alfa›

A16AB25 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes

Indicated for: lysosomal enzyme deficiency

Olmesartan medoxomil›

C09CA08 Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain

Indicated for: hypertension

Olmesartan medoxomil + amlodipine›

C09DB02 Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers

Indicated for: hypertension

Olmesartan + amlodipine›

C09DB02 Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers

Indicated for: hypertension

Olmesartan + amlodipine + hydrochlorothiazide›

C09DX03 Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs), other combinations

Indicated for: hypertension

Olmesartan + hydrochlorothiazide›

C09DA08 Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics

Indicated for: hypertension

Olodaterol›

R03AC19 Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists

Indicated for: chronic obstructive pulmonary disease

Olopatadine›

S01GX09 Sensory organs | Decongestants and antiallergics | Other antiallergics

Indicated for: allergic rhinitis; urticaria

Olopatadine + mometasone›

R01AD59 Respiratory system | Decongestants and other nasal preparations for topical use | Corticosteroids

Indicated for: allergic rhinitis

Omalizumab›

R03DX05 Respiratory system | Other systemic drugs for obstructive airway diseases

Indicated for: severe allergic asthma; chronic spontaneous urticaria; chronic rhinosinusitis with nasal polyps

Omaveloxolon›

N07XX25 Nervous system | Other nervous system drugs | Other nervous system drugs

Indicated for: Friedreich ataxia

Ombitasvir + paritaprevir + ritonavir›

J05AP53 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections

Indicated for: HIV-1 infection

Omega-3-ethyl esters 90›

C10AX06 Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Other lipid modifying agents

Indicated for: hypertriglyceridemia

Omeprazole›

A02BC01 Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors

Indicated for: peptic ulcer; gastroesophageal reflux